Tony Sandler

343 timestamped statements across 10 topics — auto-found in recorded discussions, each timestamp jumps to the exact moment.

Abdominal Wall Defects · guest expert Adrenal Tumors · guest expert Colorectal / ARM & Hirschsprung · guest expert Etiologies (Gastroschisis/NEC/Atresia/Volvulus) · guest expert Intestinal Rehab · guest expert Neuroblastoma · guest expert Soft Tissue Sarcoma (lymph nodes) · guest expert Wilms Tumor · guest expert

Featured statements

▶ Ep 2 · 33:10
If NMEC is amplified, it is automatically high-risk disease, irrespective of any other categorization.
▶ Ep 8 · 1:32
Current standard for bilateral Wilms tumor is to start chemotherapy without biopsy, typically 2 cycles, and continue until tumor shrinkage plateaus (defined as less than 50% size reduction)
▶ Ep 4 · 1:32
Current standard for bilateral Wilms tumor is to start chemotherapy, give 2 cycles, and stop when tumor shrinkage plateaus (defined as less than 50% volume reduction).
▶ Ep 1 · 23:50
Complete staging workup includes bone marrow biopsy, MIBG scan, chest CT to rule out metastasis, and head CT if clinical symptoms present
guideline · Neuroblastoma
▶ Ep 1 · 14:36
5 centimeters is used as size cutoff for surgical intervention in observed prenatal masses
guideline · Neuroblastoma
▶ Ep 2 · 35:25
Age cutoff for neuroblastoma risk stratification is 18 months (previously was 12 months)
guideline · Adrenal Tumors

Nothing matches these filters — clear the search or widen the filters.

Tony's statements about Abdominal Wall Defects 48 statements

Open the Abdominal Wall Defects collection →

Bilateral Wilm's Tumor - Complex Gastroschisis - Complex Ileal Atresia:...

▶ Ep 4 · 1:32
guideline Current standard for bilateral Wilms tumor is to start chemotherapy, give 2 cycles, and stop when tumor shrinkage plateaus (defined as less than 50% volume reduction). ↗
▶ Ep 4 · 4:19
clinical When Wilms tumors stop shrinking with chemotherapy, it is usually due to mesenchymal differentiation rather than anaplastic transformation. ↗
▶ Ep 4 · 4:44
clinical Bilateral nephron-sparing surgery for Wilms tumor can be performed by placing kidneys on ice, clamping vessels, and performing sharp tumor dissection—surprisingly feasible even for large tumors. ↗
▶ Ep 4 · 5:58
quote I never like to stick around for post-op complications. ↗
▶ Ep 4 · 7:56
opinion It is debated whether anaplasia in Wilms tumor is present initially or develops secondary to chemotherapy-induced differentiation; most pathologists believe it is present primarily, making these heterogeneous tumors. ↗
▶ Ep 4 · 9:12
epidemiological 97% of bilateral kidney tumors in children are Wilms tumor, so biopsy is not needed upfront—chemotherapy should be started empirically. ↗
▶ Ep 4 · 12:54
clinical For gastroschisis closure using Tegaderm technique, if the fascia is not cut to widen the defect, most umbilical hernias will close spontaneously and do not require repair. ↗
▶ Ep 4 · 14:52
clinical Tegaderm can be applied directly over reduced gastroschisis without Betadine or other topical agents, left in place for approximately 3 days, then converted to dry dressing once tissues are adherent. ↗
▶ Ep 4 · 15:32
clinical Even when a gastroschisis silo fails and the defect dilates significantly, Tegaderm-only closure can achieve successful cicatrization over 8 weeks. ↗
▶ Ep 4 · 19:26
clinical When gastroschisis is reduced without closing the fascia, ambient intra-abdominal pressure is lower than with fascial closure, which may benefit bowel function. ↗
▶ Ep 4 · 19:48
quote I wasn't smart enough to bring it out through the umbilicus. ↗
▶ Ep 4 · 22:07
clinical Re-exploration at 2 weeks after initial gastroschisis reduction (rather than the traditional 4-6 weeks) can reveal that inflamed 'gastroschisis bowel' has transformed into viable intestine suitable for anastomosis. ↗
▶ Ep 4 · 24:21
clinical For apple-peel ileal atresia with ischemic distal bowel, if the bowel does not pink up on the operating table and is not twisted, resection with primary anastomosis is appropriate. ↗
▶ Ep 4 · 25:37
clinical Plication of massively dilated proximal bowel in intestinal atresia is helpful and the plication typically unravels over time, preserving bowel length for later lengthening procedures if needed. ↗
▶ Ep 4 · 28:10
clinical In newborns with questionable short-gut syndrome, tapering should be avoided to preserve bowel for potential lengthening procedures later; plication is preferred. ↗
▶ Ep 4 · 28:23
clinical If a child has extensive bowel length and only a segment is dilated, tapering is reasonable. ↗

Compiled Sandler Rapid Fire Sessions: Update Course 2015

▶ Ep 8 · 0:28
quote I congratulate you for putting on an incredible symposium ↗
▶ Ep 8 · 0:28
quote I congratulate you for putting on an incredible symposium ↗
▶ Ep 8 · 1:32
guideline Current standard for bilateral Wilms tumor is to start chemotherapy without biopsy, typically 2 cycles, and continue until tumor shrinkage plateaus (defined as less than 50% size reduction) ↗
▶ Ep 8 · 1:32
guideline Current standard for bilateral Wilms tumor is to start chemotherapy without biopsy, typically 2 cycles, and continue until tumor shrinkage plateaus (defined as less than 50% size reduction) ↗
▶ Ep 8 · 4:19
clinical When Wilms tumors stop shrinking with chemotherapy, it is usually due to mesenchymal differentiation rather than anaplastic transformation ↗
▶ Ep 8 · 4:19
clinical When Wilms tumors stop shrinking with chemotherapy, it is usually due to mesenchymal differentiation rather than anaplastic transformation ↗
▶ Ep 8 · 4:44
clinical Bilateral nephron-sparing surgery is feasible even in large bilateral Wilms tumors by placing kidneys on ice, clamping vessels, and performing sharp dissection ↗
▶ Ep 8 · 4:44
clinical Bilateral nephron-sparing surgery is feasible even in large bilateral Wilms tumors by placing kidneys on ice, clamping vessels, and performing sharp dissection ↗
▶ Ep 8 · 5:58
quote I never like to stick around for post-op complications. I, I'm that's a joke, sorry. ↗
▶ Ep 8 · 5:58
quote I never like to stick around for post-op complications. I, I'm that's a joke, sorry. ↗
▶ Ep 8 · 6:46
quote They gotta look a lot. You have to look a lot. ↗
▶ Ep 8 · 6:46
quote They gotta look a lot. You have to look a lot. ↗
▶ Ep 8 · 7:56
opinion Most pathologists believe anaplasia in Wilms tumor is present primarily rather than induced by chemotherapy ↗
▶ Ep 8 · 7:56
opinion Most pathologists believe anaplasia in Wilms tumor is present primarily rather than induced by chemotherapy ↗
▶ Ep 8 · 9:12
epidemiological 97% of bilateral kidney tumors in children are Wilms tumor, with only a small percentage being other diagnoses ↗
▶ Ep 8 · 9:12
epidemiological 97% of bilateral kidney tumors in children are Wilms tumor, with only a small percentage being other diagnoses ↗
▶ Ep 8 · 12:54
clinical Umbilical hernias after gastroschisis closure will close spontaneously if no fascia was cut; if fascia is cut, a permanent defect results ↗
▶ Ep 8 · 12:54
clinical Umbilical hernias after gastroschisis closure will close spontaneously if no fascia was cut; if fascia is cut, a permanent defect results ↗
▶ Ep 8 · 14:52
clinical Tegaderm closure of gastroschisis without fascial closure allows cicatrization over 3 days to 8 weeks, with feeding started when bowel function returns rather than waiting for complete closure ↗
▶ Ep 8 · 14:52
clinical Tegaderm closure of gastroschisis without fascial closure allows cicatrization over 3 days to 8 weeks, with feeding started when bowel function returns rather than waiting for complete closure ↗
▶ Ep 8 · 15:32
clinical When gastroschisis defect dilates during silo reduction attempts, Tegaderm closure alone can still achieve successful cicatrization without fascial closure ↗
▶ Ep 8 · 15:32
clinical When gastroschisis defect dilates during silo reduction attempts, Tegaderm closure alone can still achieve successful cicatrization without fascial closure ↗
▶ Ep 8 · 21:01
clinical In vanishing gastroschisis with markedly inflamed bowel, it is impossible to determine bowel viability or the extent of remaining intra-abdominal bowel from external examination ↗
▶ Ep 8 · 21:01
clinical In vanishing gastroschisis with markedly inflamed bowel, it is impossible to determine bowel viability or the extent of remaining intra-abdominal bowel from external examination ↗
▶ Ep 8 · 21:11
quote You cannot tell what's going on with this bowel, whatever you, whatever you do. Now, something strange we did and absolutely not take it out, never take it out. ↗
▶ Ep 8 · 21:11
quote You cannot tell what's going on with this bowel, whatever you, whatever you do. Now, something strange we did and absolutely not take it out, never take it out. ↗
▶ Ep 8 · 22:07
clinical Re-exploration at 2 weeks after gastroschisis closure (rather than the traditional 4-6 weeks) can reveal that inflamed gastroschisis bowel has transformed into functional intestine suitable for anastomosis ↗
▶ Ep 8 · 22:07
clinical Re-exploration at 2 weeks after gastroschisis closure (rather than the traditional 4-6 weeks) can reveal that inflamed gastroschisis bowel has transformed into functional intestine suitable for anastomosis ↗
▶ Ep 8 · 26:13
clinical Plication of dilated bowel in ileal atresia usually unravels with time, allowing the bowel to be used later for lengthening procedures ↗
▶ Ep 8 · 26:13
clinical Plication of dilated bowel in ileal atresia usually unravels with time, allowing the bowel to be used later for lengthening procedures ↗
▶ Ep 8 · 28:10
clinical In neonatal ileal atresia with dilated proximal bowel, plication is preferred over tapering to preserve bowel length for potential future lengthening procedures ↗
▶ Ep 8 · 28:10
clinical In neonatal ileal atresia with dilated proximal bowel, plication is preferred over tapering to preserve bowel length for potential future lengthening procedures ↗
Tony's statements about Adrenal Tumors 16 statements

Open the Adrenal Tumors collection →

Neuroblastoma

▶ Ep 2 · 3:27
epidemiological Familial neuroblastoma occurs in approximately 1% of patients ↗
▶ Ep 2 · 8:41
quote I think one of the other things when you speak to the family, it's really important to reassure them that even if the mass increases in size and you take it out, it is likely to be a very, very low risk tumor. ↗
▶ Ep 2 · 9:09
clinical In the GetNucturne observation study of 84 patients, 16 (approximately 20%) underwent resection for growth or family preference, with 98% event-free survival and 100% overall survival ↗
▶ Ep 2 · 12:43
opinion Five centimeters is the size cutoff where most experts recommend surgical resection of neonatal neuroblastoma ↗
▶ Ep 2 · 23:50
clinical Open biopsy via retroperitoneal approach allows adequate tissue for NMEC amplification, ALK mutation, ploidy, and 11q status ↗
▶ Ep 2 · 31:38
clinical NMEC amplification automatically means high-risk neuroblastoma regardless of other factors ↗
▶ Ep 2 · 32:32
quote I sort of think of it like imperforate anus. And you think of it as there's different ways of classifying imperforate anus. But for me, practically, there's high and there's low. ↗
▶ Ep 2 · 33:10
quote If NMEC is amplified, it is automatically high-risk disease, irrespective of any other categorization. ↗
▶ Ep 2 · 35:25
guideline Age cutoff for neuroblastoma risk stratification is 18 months (previously was 12 months) ↗
▶ Ep 2 · 45:31
clinical Stem cell harvesting for high-risk neuroblastoma typically occurs after cycle 2 of chemotherapy ↗
▶ Ep 2 · 46:50
clinical Recent German/European publication stated unequivocally that extent of resection does not make a difference in neuroblastoma outcomes ↗
▶ Ep 2 · 47:20
quote I think the bottom line is patients don't die of local disease. They die of systemic disease, in neuroblastoma. ↗
▶ Ep 2 · 47:40
clinical High-risk neuroblastoma patients die of metastatic disease, not local disease recurrence ↗
▶ Ep 2 · 53:13
clinical Nephrectomy should be avoided in neuroblastoma resection because kidney removal requires chemotherapy dose reduction ↗
▶ Ep 2 · 53:44
clinical Anti-GD2 monoclonal antibody improved high-risk neuroblastoma two-year survival from 46% to 60% ↗
▶ Ep 2 · 54:40
clinical Checkpoint inhibitors have not been successful in neuroblastoma because it is not an immunogenic tumor ↗
Tony's statements about Colorectal / ARM & Hirschsprung 16 statements

Open the Colorectal / ARM & Hirschsprung collection →

Neuroblastoma

▶ Ep 74 · 3:27
epidemiological Familial neuroblastoma occurs in approximately 1% of patients ↗
▶ Ep 74 · 8:41
quote I think one of the other things when you speak to the family, it's really important to reassure them that even if the mass increases in size and you take it out, it is likely to be a very, very low risk tumor. ↗
▶ Ep 74 · 9:09
clinical In the GetNucturne observation study of 84 patients, 16 (approximately 20%) underwent resection for growth or family preference, with 98% event-free survival and 100% overall survival ↗
▶ Ep 74 · 12:43
opinion Five centimeters is the size cutoff where most experts recommend surgical resection of neonatal neuroblastoma ↗
▶ Ep 74 · 23:50
clinical Open biopsy via retroperitoneal approach allows adequate tissue for NMEC amplification, ALK mutation, ploidy, and 11q status ↗
▶ Ep 74 · 31:38
clinical NMEC amplification automatically means high-risk neuroblastoma regardless of other factors ↗
▶ Ep 74 · 32:32
quote I sort of think of it like imperforate anus. And you think of it as there's different ways of classifying imperforate anus. But for me, practically, there's high and there's low. ↗
▶ Ep 74 · 33:10
quote If NMEC is amplified, it is automatically high-risk disease, irrespective of any other categorization. ↗
▶ Ep 74 · 35:25
guideline Age cutoff for neuroblastoma risk stratification is 18 months (previously was 12 months) ↗
▶ Ep 74 · 45:31
clinical Stem cell harvesting for high-risk neuroblastoma typically occurs after cycle 2 of chemotherapy ↗
▶ Ep 74 · 46:50
clinical Recent German/European publication stated unequivocally that extent of resection does not make a difference in neuroblastoma outcomes ↗
▶ Ep 74 · 47:20
quote I think the bottom line is patients don't die of local disease. They die of systemic disease, in neuroblastoma. ↗
▶ Ep 74 · 47:40
clinical High-risk neuroblastoma patients die of metastatic disease, not local disease recurrence ↗
▶ Ep 74 · 53:13
clinical Nephrectomy should be avoided in neuroblastoma resection because kidney removal requires chemotherapy dose reduction ↗
▶ Ep 74 · 53:44
clinical Anti-GD2 monoclonal antibody improved high-risk neuroblastoma two-year survival from 46% to 60% ↗
▶ Ep 74 · 54:40
clinical Checkpoint inhibitors have not been successful in neuroblastoma because it is not an immunogenic tumor ↗
Tony's statements about Etiologies (Gastroschisis/NEC/Atresia/Volvulus) 48 statements

Open the Etiologies (Gastroschisis/NEC/Atresia/Volvulus) collection →

Bilateral Wilm's Tumor - Complex Gastroschisis - Complex Ileal Atresia:...

▶ Ep 5 · 1:32
guideline Current standard for bilateral Wilms tumor is to start chemotherapy, give 2 cycles, and stop when tumor shrinkage plateaus (defined as less than 50% volume reduction). ↗
▶ Ep 5 · 4:19
clinical When Wilms tumors stop shrinking with chemotherapy, it is usually due to mesenchymal differentiation rather than anaplastic transformation. ↗
▶ Ep 5 · 4:44
clinical Bilateral nephron-sparing surgery for Wilms tumor can be performed by placing kidneys on ice, clamping vessels, and performing sharp tumor dissection—surprisingly feasible even for large tumors. ↗
▶ Ep 5 · 5:58
quote I never like to stick around for post-op complications. ↗
▶ Ep 5 · 7:56
opinion It is debated whether anaplasia in Wilms tumor is present initially or develops secondary to chemotherapy-induced differentiation; most pathologists believe it is present primarily, making these heterogeneous tumors. ↗
▶ Ep 5 · 9:12
epidemiological 97% of bilateral kidney tumors in children are Wilms tumor, so biopsy is not needed upfront—chemotherapy should be started empirically. ↗
▶ Ep 5 · 12:54
clinical For gastroschisis closure using Tegaderm technique, if the fascia is not cut to widen the defect, most umbilical hernias will close spontaneously and do not require repair. ↗
▶ Ep 5 · 14:52
clinical Tegaderm can be applied directly over reduced gastroschisis without Betadine or other topical agents, left in place for approximately 3 days, then converted to dry dressing once tissues are adherent. ↗
▶ Ep 5 · 15:32
clinical Even when a gastroschisis silo fails and the defect dilates significantly, Tegaderm-only closure can achieve successful cicatrization over 8 weeks. ↗
▶ Ep 5 · 19:26
clinical When gastroschisis is reduced without closing the fascia, ambient intra-abdominal pressure is lower than with fascial closure, which may benefit bowel function. ↗
▶ Ep 5 · 19:48
quote I wasn't smart enough to bring it out through the umbilicus. ↗
▶ Ep 5 · 22:07
clinical Re-exploration at 2 weeks after initial gastroschisis reduction (rather than the traditional 4-6 weeks) can reveal that inflamed 'gastroschisis bowel' has transformed into viable intestine suitable for anastomosis. ↗
▶ Ep 5 · 24:21
clinical For apple-peel ileal atresia with ischemic distal bowel, if the bowel does not pink up on the operating table and is not twisted, resection with primary anastomosis is appropriate. ↗
▶ Ep 5 · 25:37
clinical Plication of massively dilated proximal bowel in intestinal atresia is helpful and the plication typically unravels over time, preserving bowel length for later lengthening procedures if needed. ↗
▶ Ep 5 · 28:10
clinical In newborns with questionable short-gut syndrome, tapering should be avoided to preserve bowel for potential lengthening procedures later; plication is preferred. ↗
▶ Ep 5 · 28:23
clinical If a child has extensive bowel length and only a segment is dilated, tapering is reasonable. ↗

Compiled Sandler Rapid Fire Sessions: Update Course 2015

▶ Ep 12 · 0:28
quote I congratulate you for putting on an incredible symposium ↗
▶ Ep 12 · 0:28
quote I congratulate you for putting on an incredible symposium ↗
▶ Ep 12 · 1:32
guideline Current standard for bilateral Wilms tumor is to start chemotherapy without biopsy, typically 2 cycles, and continue until tumor shrinkage plateaus (defined as less than 50% size reduction) ↗
▶ Ep 12 · 1:32
guideline Current standard for bilateral Wilms tumor is to start chemotherapy without biopsy, typically 2 cycles, and continue until tumor shrinkage plateaus (defined as less than 50% size reduction) ↗
▶ Ep 12 · 4:19
clinical When Wilms tumors stop shrinking with chemotherapy, it is usually due to mesenchymal differentiation rather than anaplastic transformation ↗
▶ Ep 12 · 4:19
clinical When Wilms tumors stop shrinking with chemotherapy, it is usually due to mesenchymal differentiation rather than anaplastic transformation ↗
▶ Ep 12 · 4:44
clinical Bilateral nephron-sparing surgery is feasible even in large bilateral Wilms tumors by placing kidneys on ice, clamping vessels, and performing sharp dissection ↗
▶ Ep 12 · 4:44
clinical Bilateral nephron-sparing surgery is feasible even in large bilateral Wilms tumors by placing kidneys on ice, clamping vessels, and performing sharp dissection ↗
▶ Ep 12 · 5:58
quote I never like to stick around for post-op complications. I, I'm that's a joke, sorry. ↗
▶ Ep 12 · 5:58
quote I never like to stick around for post-op complications. I, I'm that's a joke, sorry. ↗
▶ Ep 12 · 6:46
quote They gotta look a lot. You have to look a lot. ↗
▶ Ep 12 · 6:46
quote They gotta look a lot. You have to look a lot. ↗
▶ Ep 12 · 7:56
opinion Most pathologists believe anaplasia in Wilms tumor is present primarily rather than induced by chemotherapy ↗
▶ Ep 12 · 7:56
opinion Most pathologists believe anaplasia in Wilms tumor is present primarily rather than induced by chemotherapy ↗
▶ Ep 12 · 9:12
epidemiological 97% of bilateral kidney tumors in children are Wilms tumor, with only a small percentage being other diagnoses ↗
▶ Ep 12 · 9:12
epidemiological 97% of bilateral kidney tumors in children are Wilms tumor, with only a small percentage being other diagnoses ↗
▶ Ep 12 · 12:54
clinical Umbilical hernias after gastroschisis closure will close spontaneously if no fascia was cut; if fascia is cut, a permanent defect results ↗
▶ Ep 12 · 12:54
clinical Umbilical hernias after gastroschisis closure will close spontaneously if no fascia was cut; if fascia is cut, a permanent defect results ↗
▶ Ep 12 · 14:52
clinical Tegaderm closure of gastroschisis without fascial closure allows cicatrization over 3 days to 8 weeks, with feeding started when bowel function returns rather than waiting for complete closure ↗
▶ Ep 12 · 14:52
clinical Tegaderm closure of gastroschisis without fascial closure allows cicatrization over 3 days to 8 weeks, with feeding started when bowel function returns rather than waiting for complete closure ↗
▶ Ep 12 · 15:32
clinical When gastroschisis defect dilates during silo reduction attempts, Tegaderm closure alone can still achieve successful cicatrization without fascial closure ↗
▶ Ep 12 · 15:32
clinical When gastroschisis defect dilates during silo reduction attempts, Tegaderm closure alone can still achieve successful cicatrization without fascial closure ↗
▶ Ep 12 · 21:01
clinical In vanishing gastroschisis with markedly inflamed bowel, it is impossible to determine bowel viability or the extent of remaining intra-abdominal bowel from external examination ↗
▶ Ep 12 · 21:01
clinical In vanishing gastroschisis with markedly inflamed bowel, it is impossible to determine bowel viability or the extent of remaining intra-abdominal bowel from external examination ↗
▶ Ep 12 · 21:11
quote You cannot tell what's going on with this bowel, whatever you, whatever you do. Now, something strange we did and absolutely not take it out, never take it out. ↗
▶ Ep 12 · 21:11
quote You cannot tell what's going on with this bowel, whatever you, whatever you do. Now, something strange we did and absolutely not take it out, never take it out. ↗
▶ Ep 12 · 22:07
clinical Re-exploration at 2 weeks after gastroschisis closure (rather than the traditional 4-6 weeks) can reveal that inflamed gastroschisis bowel has transformed into functional intestine suitable for anastomosis ↗
▶ Ep 12 · 22:07
clinical Re-exploration at 2 weeks after gastroschisis closure (rather than the traditional 4-6 weeks) can reveal that inflamed gastroschisis bowel has transformed into functional intestine suitable for anastomosis ↗
▶ Ep 12 · 26:13
clinical Plication of dilated bowel in ileal atresia usually unravels with time, allowing the bowel to be used later for lengthening procedures ↗
▶ Ep 12 · 26:13
clinical Plication of dilated bowel in ileal atresia usually unravels with time, allowing the bowel to be used later for lengthening procedures ↗
▶ Ep 12 · 28:10
clinical In neonatal ileal atresia with dilated proximal bowel, plication is preferred over tapering to preserve bowel length for potential future lengthening procedures ↗
▶ Ep 12 · 28:10
clinical In neonatal ileal atresia with dilated proximal bowel, plication is preferred over tapering to preserve bowel length for potential future lengthening procedures ↗
Tony's statements about Intestinal Rehab 48 statements

Open the Intestinal Rehab collection →

Bilateral Wilm's Tumor - Complex Gastroschisis - Complex Ileal Atresia:...

▶ Ep 6 · 1:32
guideline Current standard for bilateral Wilms tumor is to start chemotherapy, give 2 cycles, and stop when tumor shrinkage plateaus (defined as less than 50% volume reduction). ↗
▶ Ep 6 · 4:19
clinical When Wilms tumors stop shrinking with chemotherapy, it is usually due to mesenchymal differentiation rather than anaplastic transformation. ↗
▶ Ep 6 · 4:44
clinical Bilateral nephron-sparing surgery for Wilms tumor can be performed by placing kidneys on ice, clamping vessels, and performing sharp tumor dissection—surprisingly feasible even for large tumors. ↗
▶ Ep 6 · 5:58
quote I never like to stick around for post-op complications. ↗
▶ Ep 6 · 7:56
opinion It is debated whether anaplasia in Wilms tumor is present initially or develops secondary to chemotherapy-induced differentiation; most pathologists believe it is present primarily, making these heterogeneous tumors. ↗
▶ Ep 6 · 9:12
epidemiological 97% of bilateral kidney tumors in children are Wilms tumor, so biopsy is not needed upfront—chemotherapy should be started empirically. ↗
▶ Ep 6 · 12:54
clinical For gastroschisis closure using Tegaderm technique, if the fascia is not cut to widen the defect, most umbilical hernias will close spontaneously and do not require repair. ↗
▶ Ep 6 · 14:52
clinical Tegaderm can be applied directly over reduced gastroschisis without Betadine or other topical agents, left in place for approximately 3 days, then converted to dry dressing once tissues are adherent. ↗
▶ Ep 6 · 15:32
clinical Even when a gastroschisis silo fails and the defect dilates significantly, Tegaderm-only closure can achieve successful cicatrization over 8 weeks. ↗
▶ Ep 6 · 19:26
clinical When gastroschisis is reduced without closing the fascia, ambient intra-abdominal pressure is lower than with fascial closure, which may benefit bowel function. ↗
▶ Ep 6 · 19:48
quote I wasn't smart enough to bring it out through the umbilicus. ↗
▶ Ep 6 · 22:07
clinical Re-exploration at 2 weeks after initial gastroschisis reduction (rather than the traditional 4-6 weeks) can reveal that inflamed 'gastroschisis bowel' has transformed into viable intestine suitable for anastomosis. ↗
▶ Ep 6 · 24:21
clinical For apple-peel ileal atresia with ischemic distal bowel, if the bowel does not pink up on the operating table and is not twisted, resection with primary anastomosis is appropriate. ↗
▶ Ep 6 · 25:37
clinical Plication of massively dilated proximal bowel in intestinal atresia is helpful and the plication typically unravels over time, preserving bowel length for later lengthening procedures if needed. ↗
▶ Ep 6 · 28:10
clinical In newborns with questionable short-gut syndrome, tapering should be avoided to preserve bowel for potential lengthening procedures later; plication is preferred. ↗
▶ Ep 6 · 28:23
clinical If a child has extensive bowel length and only a segment is dilated, tapering is reasonable. ↗

Compiled Sandler Rapid Fire Sessions: Update Course 2015

▶ Ep 19 · 0:28
quote I congratulate you for putting on an incredible symposium ↗
▶ Ep 19 · 0:28
quote I congratulate you for putting on an incredible symposium ↗
▶ Ep 19 · 1:32
guideline Current standard for bilateral Wilms tumor is to start chemotherapy without biopsy, typically 2 cycles, and continue until tumor shrinkage plateaus (defined as less than 50% size reduction) ↗
▶ Ep 19 · 1:32
guideline Current standard for bilateral Wilms tumor is to start chemotherapy without biopsy, typically 2 cycles, and continue until tumor shrinkage plateaus (defined as less than 50% size reduction) ↗
▶ Ep 19 · 4:19
clinical When Wilms tumors stop shrinking with chemotherapy, it is usually due to mesenchymal differentiation rather than anaplastic transformation ↗
▶ Ep 19 · 4:19
clinical When Wilms tumors stop shrinking with chemotherapy, it is usually due to mesenchymal differentiation rather than anaplastic transformation ↗
▶ Ep 19 · 4:44
clinical Bilateral nephron-sparing surgery is feasible even in large bilateral Wilms tumors by placing kidneys on ice, clamping vessels, and performing sharp dissection ↗
▶ Ep 19 · 4:44
clinical Bilateral nephron-sparing surgery is feasible even in large bilateral Wilms tumors by placing kidneys on ice, clamping vessels, and performing sharp dissection ↗
▶ Ep 19 · 5:58
quote I never like to stick around for post-op complications. I, I'm that's a joke, sorry. ↗
▶ Ep 19 · 5:58
quote I never like to stick around for post-op complications. I, I'm that's a joke, sorry. ↗
▶ Ep 19 · 6:46
quote They gotta look a lot. You have to look a lot. ↗
▶ Ep 19 · 6:46
quote They gotta look a lot. You have to look a lot. ↗
▶ Ep 19 · 7:56
opinion Most pathologists believe anaplasia in Wilms tumor is present primarily rather than induced by chemotherapy ↗
▶ Ep 19 · 7:56
opinion Most pathologists believe anaplasia in Wilms tumor is present primarily rather than induced by chemotherapy ↗
▶ Ep 19 · 9:12
epidemiological 97% of bilateral kidney tumors in children are Wilms tumor, with only a small percentage being other diagnoses ↗
▶ Ep 19 · 9:12
epidemiological 97% of bilateral kidney tumors in children are Wilms tumor, with only a small percentage being other diagnoses ↗
▶ Ep 19 · 12:54
clinical Umbilical hernias after gastroschisis closure will close spontaneously if no fascia was cut; if fascia is cut, a permanent defect results ↗
▶ Ep 19 · 12:54
clinical Umbilical hernias after gastroschisis closure will close spontaneously if no fascia was cut; if fascia is cut, a permanent defect results ↗
▶ Ep 19 · 14:52
clinical Tegaderm closure of gastroschisis without fascial closure allows cicatrization over 3 days to 8 weeks, with feeding started when bowel function returns rather than waiting for complete closure ↗
▶ Ep 19 · 14:52
clinical Tegaderm closure of gastroschisis without fascial closure allows cicatrization over 3 days to 8 weeks, with feeding started when bowel function returns rather than waiting for complete closure ↗
▶ Ep 19 · 15:32
clinical When gastroschisis defect dilates during silo reduction attempts, Tegaderm closure alone can still achieve successful cicatrization without fascial closure ↗
▶ Ep 19 · 15:32
clinical When gastroschisis defect dilates during silo reduction attempts, Tegaderm closure alone can still achieve successful cicatrization without fascial closure ↗
▶ Ep 19 · 21:01
clinical In vanishing gastroschisis with markedly inflamed bowel, it is impossible to determine bowel viability or the extent of remaining intra-abdominal bowel from external examination ↗
▶ Ep 19 · 21:01
clinical In vanishing gastroschisis with markedly inflamed bowel, it is impossible to determine bowel viability or the extent of remaining intra-abdominal bowel from external examination ↗
▶ Ep 19 · 21:11
quote You cannot tell what's going on with this bowel, whatever you, whatever you do. Now, something strange we did and absolutely not take it out, never take it out. ↗
▶ Ep 19 · 21:11
quote You cannot tell what's going on with this bowel, whatever you, whatever you do. Now, something strange we did and absolutely not take it out, never take it out. ↗
▶ Ep 19 · 22:07
clinical Re-exploration at 2 weeks after gastroschisis closure (rather than the traditional 4-6 weeks) can reveal that inflamed gastroschisis bowel has transformed into functional intestine suitable for anastomosis ↗
▶ Ep 19 · 22:07
clinical Re-exploration at 2 weeks after gastroschisis closure (rather than the traditional 4-6 weeks) can reveal that inflamed gastroschisis bowel has transformed into functional intestine suitable for anastomosis ↗
▶ Ep 19 · 26:13
clinical Plication of dilated bowel in ileal atresia usually unravels with time, allowing the bowel to be used later for lengthening procedures ↗
▶ Ep 19 · 26:13
clinical Plication of dilated bowel in ileal atresia usually unravels with time, allowing the bowel to be used later for lengthening procedures ↗
▶ Ep 19 · 28:10
clinical In neonatal ileal atresia with dilated proximal bowel, plication is preferred over tapering to preserve bowel length for potential future lengthening procedures ↗
▶ Ep 19 · 28:10
clinical In neonatal ileal atresia with dilated proximal bowel, plication is preferred over tapering to preserve bowel length for potential future lengthening procedures ↗
Tony's statements about Neuroblastoma 29 statements

Open the Neuroblastoma collection →

Neuroblastoma

▶ Ep 1 · 3:51
quote The priority during the pregnancy is the mom. And once the baby is born, then we'll learn more and the first thing we'll do is get more information once the baby is born. ↗
▶ Ep 1 · 4:39
epidemiological Familial neuroblastoma occurs in about 1% of patients ↗
▶ Ep 1 · 5:34
guideline CT scan or MRI not needed for 3 cm lesion unless urine catecholamines are elevated ↗
▶ Ep 1 · 10:39
epidemiological Of 84 observed patients in Nocktern study, 16 (approximately 20%) underwent resection for growth or family preference ↗
▶ Ep 1 · 14:36
guideline 5 centimeters is used as size cutoff for surgical intervention in observed prenatal masses ↗
▶ Ep 1 · 22:56
clinical Ultrasound is important for Wilms tumor to assess venous extension ↗
▶ Ep 1 · 23:50
guideline Complete staging workup includes bone marrow biopsy, MIBG scan, chest CT to rule out metastasis, and head CT if clinical symptoms present ↗
▶ Ep 1 · 23:50
clinical Large mass encasing aorta and celiac axis with microcalcifications represents L2 INRG classification ↗
▶ Ep 1 · 27:10
clinical NMYC amplification can be obtained from bone marrow, but additional biology studies require tumor tissue ↗
▶ Ep 1 · 27:10
opinion Multiple percutaneous biopsies may not provide adequate tissue for biology studies ↗
▶ Ep 1 · 27:10
opinion Transperitoneal laparoscopic biopsy may not allow adequate bleeding control for large tumors ↗
▶ Ep 1 · 27:10
opinion Open retroperitoneal biopsy provides adequate tissue size for pathology and biology studies ↗
▶ Ep 1 · 28:28
clinical Biology studies beyond NMYC include ALK mutation and ploidy status ↗

Neuroblastoma

▶ Ep 3 · 3:27
epidemiological Familial neuroblastoma occurs in approximately 1% of patients ↗
▶ Ep 3 · 8:41
quote I think one of the other things when you speak to the family, it's really important to reassure them that even if the mass increases in size and you take it out, it is likely to be a very, very low risk tumor. ↗
▶ Ep 3 · 9:09
clinical In the GetNucturne observation study of 84 patients, 16 (approximately 20%) underwent resection for growth or family preference, with 98% event-free survival and 100% overall survival ↗
▶ Ep 3 · 12:43
opinion Five centimeters is the size cutoff where most experts recommend surgical resection of neonatal neuroblastoma ↗
▶ Ep 3 · 23:50
clinical Open biopsy via retroperitoneal approach allows adequate tissue for NMEC amplification, ALK mutation, ploidy, and 11q status ↗
▶ Ep 3 · 31:38
clinical NMEC amplification automatically means high-risk neuroblastoma regardless of other factors ↗
▶ Ep 3 · 32:32
quote I sort of think of it like imperforate anus. And you think of it as there's different ways of classifying imperforate anus. But for me, practically, there's high and there's low. ↗
▶ Ep 3 · 33:10
quote If NMEC is amplified, it is automatically high-risk disease, irrespective of any other categorization. ↗
▶ Ep 3 · 35:25
guideline Age cutoff for neuroblastoma risk stratification is 18 months (previously was 12 months) ↗
▶ Ep 3 · 45:31
clinical Stem cell harvesting for high-risk neuroblastoma typically occurs after cycle 2 of chemotherapy ↗
▶ Ep 3 · 46:50
clinical Recent German/European publication stated unequivocally that extent of resection does not make a difference in neuroblastoma outcomes ↗
▶ Ep 3 · 47:20
quote I think the bottom line is patients don't die of local disease. They die of systemic disease, in neuroblastoma. ↗
▶ Ep 3 · 47:40
clinical High-risk neuroblastoma patients die of metastatic disease, not local disease recurrence ↗
▶ Ep 3 · 53:13
clinical Nephrectomy should be avoided in neuroblastoma resection because kidney removal requires chemotherapy dose reduction ↗
▶ Ep 3 · 53:44
clinical Anti-GD2 monoclonal antibody improved high-risk neuroblastoma two-year survival from 46% to 60% ↗
▶ Ep 3 · 54:40
clinical Checkpoint inhibitors have not been successful in neuroblastoma because it is not an immunogenic tumor ↗
Tony's statements about Neuroblastoma 29 statements

Open the Neuroblastoma collection →

Neuroblastoma

▶ Ep 3 · 3:51
quote The priority during the pregnancy is the mom. And once the baby is born, then we'll learn more and the first thing we'll do is get more information once the baby is born. ↗
▶ Ep 3 · 4:39
epidemiological Familial neuroblastoma occurs in about 1% of patients ↗
▶ Ep 3 · 5:34
guideline CT scan or MRI not needed for 3 cm lesion unless urine catecholamines are elevated ↗
▶ Ep 3 · 10:39
epidemiological Of 84 observed patients in Nocktern study, 16 (approximately 20%) underwent resection for growth or family preference ↗
▶ Ep 3 · 14:36
guideline 5 centimeters is used as size cutoff for surgical intervention in observed prenatal masses ↗
▶ Ep 3 · 22:56
clinical Ultrasound is important for Wilms tumor to assess venous extension ↗
▶ Ep 3 · 23:50
clinical Large mass encasing aorta and celiac axis with microcalcifications represents L2 INRG classification ↗
▶ Ep 3 · 23:50
guideline Complete staging workup includes bone marrow biopsy, MIBG scan, chest CT to rule out metastasis, and head CT if clinical symptoms present ↗
▶ Ep 3 · 27:10
opinion Open retroperitoneal biopsy provides adequate tissue size for pathology and biology studies ↗
▶ Ep 3 · 27:10
opinion Transperitoneal laparoscopic biopsy may not allow adequate bleeding control for large tumors ↗
▶ Ep 3 · 27:10
opinion Multiple percutaneous biopsies may not provide adequate tissue for biology studies ↗
▶ Ep 3 · 27:10
clinical NMYC amplification can be obtained from bone marrow, but additional biology studies require tumor tissue ↗
▶ Ep 3 · 28:28
clinical Biology studies beyond NMYC include ALK mutation and ploidy status ↗

Neuroblastoma

▶ Ep 6 · 3:27
epidemiological Familial neuroblastoma occurs in approximately 1% of patients ↗
▶ Ep 6 · 8:41
quote I think one of the other things when you speak to the family, it's really important to reassure them that even if the mass increases in size and you take it out, it is likely to be a very, very low risk tumor. ↗
▶ Ep 6 · 9:09
clinical In the GetNucturne observation study of 84 patients, 16 (approximately 20%) underwent resection for growth or family preference, with 98% event-free survival and 100% overall survival ↗
▶ Ep 6 · 12:43
opinion Five centimeters is the size cutoff where most experts recommend surgical resection of neonatal neuroblastoma ↗
▶ Ep 6 · 23:50
clinical Open biopsy via retroperitoneal approach allows adequate tissue for NMEC amplification, ALK mutation, ploidy, and 11q status ↗
▶ Ep 6 · 31:38
clinical NMEC amplification automatically means high-risk neuroblastoma regardless of other factors ↗
▶ Ep 6 · 32:32
quote I sort of think of it like imperforate anus. And you think of it as there's different ways of classifying imperforate anus. But for me, practically, there's high and there's low. ↗
▶ Ep 6 · 33:10
quote If NMEC is amplified, it is automatically high-risk disease, irrespective of any other categorization. ↗
▶ Ep 6 · 35:25
guideline Age cutoff for neuroblastoma risk stratification is 18 months (previously was 12 months) ↗
▶ Ep 6 · 45:31
clinical Stem cell harvesting for high-risk neuroblastoma typically occurs after cycle 2 of chemotherapy ↗
▶ Ep 6 · 46:50
clinical Recent German/European publication stated unequivocally that extent of resection does not make a difference in neuroblastoma outcomes ↗
▶ Ep 6 · 47:20
quote I think the bottom line is patients don't die of local disease. They die of systemic disease, in neuroblastoma. ↗
▶ Ep 6 · 47:40
clinical High-risk neuroblastoma patients die of metastatic disease, not local disease recurrence ↗
▶ Ep 6 · 53:13
clinical Nephrectomy should be avoided in neuroblastoma resection because kidney removal requires chemotherapy dose reduction ↗
▶ Ep 6 · 53:44
clinical Anti-GD2 monoclonal antibody improved high-risk neuroblastoma two-year survival from 46% to 60% ↗
▶ Ep 6 · 54:40
clinical Checkpoint inhibitors have not been successful in neuroblastoma because it is not an immunogenic tumor ↗
Tony's statements about Pediatric Oncology 61 statements

Open the Pediatric Oncology collection →

Bilateral Wilm's Tumor - Complex Gastroschisis - Complex Ileal Atresia:...

▶ Ep 53 · 1:32
guideline Current standard for bilateral Wilms tumor is to start chemotherapy, give 2 cycles, and stop when tumor shrinkage plateaus (defined as less than 50% volume reduction). ↗
▶ Ep 53 · 4:19
clinical When Wilms tumors stop shrinking with chemotherapy, it is usually due to mesenchymal differentiation rather than anaplastic transformation. ↗
▶ Ep 53 · 4:44
clinical Bilateral nephron-sparing surgery for Wilms tumor can be performed by placing kidneys on ice, clamping vessels, and performing sharp tumor dissection—surprisingly feasible even for large tumors. ↗
▶ Ep 53 · 5:58
quote I never like to stick around for post-op complications. ↗
▶ Ep 53 · 7:56
opinion It is debated whether anaplasia in Wilms tumor is present initially or develops secondary to chemotherapy-induced differentiation; most pathologists believe it is present primarily, making these heterogeneous tumors. ↗
▶ Ep 53 · 9:12
epidemiological 97% of bilateral kidney tumors in children are Wilms tumor, so biopsy is not needed upfront—chemotherapy should be started empirically. ↗
▶ Ep 53 · 12:54
clinical For gastroschisis closure using Tegaderm technique, if the fascia is not cut to widen the defect, most umbilical hernias will close spontaneously and do not require repair. ↗
▶ Ep 53 · 14:52
clinical Tegaderm can be applied directly over reduced gastroschisis without Betadine or other topical agents, left in place for approximately 3 days, then converted to dry dressing once tissues are adherent. ↗
▶ Ep 53 · 15:32
clinical Even when a gastroschisis silo fails and the defect dilates significantly, Tegaderm-only closure can achieve successful cicatrization over 8 weeks. ↗
▶ Ep 53 · 19:26
clinical When gastroschisis is reduced without closing the fascia, ambient intra-abdominal pressure is lower than with fascial closure, which may benefit bowel function. ↗
▶ Ep 53 · 19:48
quote I wasn't smart enough to bring it out through the umbilicus. ↗
▶ Ep 53 · 22:07
clinical Re-exploration at 2 weeks after initial gastroschisis reduction (rather than the traditional 4-6 weeks) can reveal that inflamed 'gastroschisis bowel' has transformed into viable intestine suitable for anastomosis. ↗
▶ Ep 53 · 24:21
clinical For apple-peel ileal atresia with ischemic distal bowel, if the bowel does not pink up on the operating table and is not twisted, resection with primary anastomosis is appropriate. ↗
▶ Ep 53 · 25:37
clinical Plication of massively dilated proximal bowel in intestinal atresia is helpful and the plication typically unravels over time, preserving bowel length for later lengthening procedures if needed. ↗
▶ Ep 53 · 28:10
clinical In newborns with questionable short-gut syndrome, tapering should be avoided to preserve bowel for potential lengthening procedures later; plication is preferred. ↗
▶ Ep 53 · 28:23
clinical If a child has extensive bowel length and only a segment is dilated, tapering is reasonable. ↗

Compiled Sandler Rapid Fire Sessions: Update Course 2015

▶ Ep 72 · 0:28
quote I congratulate you for putting on an incredible symposium ↗
▶ Ep 72 · 1:32
guideline Current standard for bilateral Wilms tumor is to start chemotherapy without biopsy, typically 2 cycles, and continue until tumor shrinkage plateaus (defined as less than 50% size reduction) ↗
▶ Ep 72 · 4:19
clinical When Wilms tumors stop shrinking with chemotherapy, it is usually due to mesenchymal differentiation rather than anaplastic transformation ↗
▶ Ep 72 · 4:44
clinical Bilateral nephron-sparing surgery is feasible even in large bilateral Wilms tumors by placing kidneys on ice, clamping vessels, and performing sharp dissection ↗
▶ Ep 72 · 5:58
quote I never like to stick around for post-op complications. I, I'm that's a joke, sorry. ↗
▶ Ep 72 · 6:46
quote They gotta look a lot. You have to look a lot. ↗
▶ Ep 72 · 7:56
opinion Most pathologists believe anaplasia in Wilms tumor is present primarily rather than induced by chemotherapy ↗
▶ Ep 72 · 9:12
epidemiological 97% of bilateral kidney tumors in children are Wilms tumor, with only a small percentage being other diagnoses ↗
▶ Ep 72 · 12:54
clinical Umbilical hernias after gastroschisis closure will close spontaneously if no fascia was cut; if fascia is cut, a permanent defect results ↗
▶ Ep 72 · 14:52
clinical Tegaderm closure of gastroschisis without fascial closure allows cicatrization over 3 days to 8 weeks, with feeding started when bowel function returns rather than waiting for complete closure ↗
▶ Ep 72 · 15:32
clinical When gastroschisis defect dilates during silo reduction attempts, Tegaderm closure alone can still achieve successful cicatrization without fascial closure ↗
▶ Ep 72 · 21:01
clinical In vanishing gastroschisis with markedly inflamed bowel, it is impossible to determine bowel viability or the extent of remaining intra-abdominal bowel from external examination ↗
▶ Ep 72 · 21:11
quote You cannot tell what's going on with this bowel, whatever you, whatever you do. Now, something strange we did and absolutely not take it out, never take it out. ↗
▶ Ep 72 · 22:07
clinical Re-exploration at 2 weeks after gastroschisis closure (rather than the traditional 4-6 weeks) can reveal that inflamed gastroschisis bowel has transformed into functional intestine suitable for anastomosis ↗
▶ Ep 72 · 26:13
clinical Plication of dilated bowel in ileal atresia usually unravels with time, allowing the bowel to be used later for lengthening procedures ↗
▶ Ep 72 · 28:10
clinical In neonatal ileal atresia with dilated proximal bowel, plication is preferred over tapering to preserve bowel length for potential future lengthening procedures ↗

Neuroblastoma

▶ Ep 184 · 3:51
quote The priority during the pregnancy is the mom. And once the baby is born, then we'll learn more and the first thing we'll do is get more information once the baby is born. ↗
▶ Ep 184 · 4:39
epidemiological Familial neuroblastoma occurs in about 1% of patients ↗
▶ Ep 184 · 5:34
guideline CT scan or MRI not needed for 3 cm lesion unless urine catecholamines are elevated ↗
▶ Ep 184 · 10:39
epidemiological Of 84 observed patients in Nocktern study, 16 (approximately 20%) underwent resection for growth or family preference ↗
▶ Ep 184 · 14:36
guideline 5 centimeters is used as size cutoff for surgical intervention in observed prenatal masses ↗
▶ Ep 184 · 22:56
clinical Ultrasound is important for Wilms tumor to assess venous extension ↗
▶ Ep 184 · 23:50
clinical Large mass encasing aorta and celiac axis with microcalcifications represents L2 INRG classification ↗
▶ Ep 184 · 23:50
guideline Complete staging workup includes bone marrow biopsy, MIBG scan, chest CT to rule out metastasis, and head CT if clinical symptoms present ↗
▶ Ep 184 · 27:10
opinion Open retroperitoneal biopsy provides adequate tissue size for pathology and biology studies ↗
▶ Ep 184 · 27:10
opinion Transperitoneal laparoscopic biopsy may not allow adequate bleeding control for large tumors ↗
▶ Ep 184 · 27:10
opinion Multiple percutaneous biopsies may not provide adequate tissue for biology studies ↗
▶ Ep 184 · 27:10
clinical NMYC amplification can be obtained from bone marrow, but additional biology studies require tumor tissue ↗
▶ Ep 184 · 28:28
clinical Biology studies beyond NMYC include ALK mutation and ploidy status ↗

Neuroblastoma

▶ Ep 252 · 3:27
epidemiological Familial neuroblastoma occurs in approximately 1% of patients ↗
▶ Ep 252 · 8:41
quote I think one of the other things when you speak to the family, it's really important to reassure them that even if the mass increases in size and you take it out, it is likely to be a very, very low risk tumor. ↗
▶ Ep 252 · 9:09
clinical In the GetNucturne observation study of 84 patients, 16 (approximately 20%) underwent resection for growth or family preference, with 98% event-free survival and 100% overall survival ↗
▶ Ep 252 · 12:43
opinion Five centimeters is the size cutoff where most experts recommend surgical resection of neonatal neuroblastoma ↗
▶ Ep 252 · 23:50
clinical Open biopsy via retroperitoneal approach allows adequate tissue for NMEC amplification, ALK mutation, ploidy, and 11q status ↗
▶ Ep 252 · 31:38
clinical NMEC amplification automatically means high-risk neuroblastoma regardless of other factors ↗
▶ Ep 252 · 32:32
quote I sort of think of it like imperforate anus. And you think of it as there's different ways of classifying imperforate anus. But for me, practically, there's high and there's low. ↗
▶ Ep 252 · 33:10
quote If NMEC is amplified, it is automatically high-risk disease, irrespective of any other categorization. ↗
▶ Ep 252 · 35:25
guideline Age cutoff for neuroblastoma risk stratification is 18 months (previously was 12 months) ↗
▶ Ep 252 · 45:31
clinical Stem cell harvesting for high-risk neuroblastoma typically occurs after cycle 2 of chemotherapy ↗
▶ Ep 252 · 46:50
clinical Recent German/European publication stated unequivocally that extent of resection does not make a difference in neuroblastoma outcomes ↗
▶ Ep 252 · 47:20
quote I think the bottom line is patients don't die of local disease. They die of systemic disease, in neuroblastoma. ↗
▶ Ep 252 · 47:40
clinical High-risk neuroblastoma patients die of metastatic disease, not local disease recurrence ↗
▶ Ep 252 · 53:13
clinical Nephrectomy should be avoided in neuroblastoma resection because kidney removal requires chemotherapy dose reduction ↗
▶ Ep 252 · 53:44
clinical Anti-GD2 monoclonal antibody improved high-risk neuroblastoma two-year survival from 46% to 60% ↗
▶ Ep 252 · 54:40
clinical Checkpoint inhibitors have not been successful in neuroblastoma because it is not an immunogenic tumor ↗
Tony's statements about Soft Tissue Sarcoma (lymph nodes) 16 statements

Open the Soft Tissue Sarcoma (lymph nodes) collection →

Neuroblastoma

▶ Ep 5 · 3:27
epidemiological Familial neuroblastoma occurs in approximately 1% of patients ↗
▶ Ep 5 · 8:41
quote I think one of the other things when you speak to the family, it's really important to reassure them that even if the mass increases in size and you take it out, it is likely to be a very, very low risk tumor. ↗
▶ Ep 5 · 9:09
clinical In the GetNucturne observation study of 84 patients, 16 (approximately 20%) underwent resection for growth or family preference, with 98% event-free survival and 100% overall survival ↗
▶ Ep 5 · 12:43
opinion Five centimeters is the size cutoff where most experts recommend surgical resection of neonatal neuroblastoma ↗
▶ Ep 5 · 23:50
clinical Open biopsy via retroperitoneal approach allows adequate tissue for NMEC amplification, ALK mutation, ploidy, and 11q status ↗
▶ Ep 5 · 31:38
clinical NMEC amplification automatically means high-risk neuroblastoma regardless of other factors ↗
▶ Ep 5 · 32:32
quote I sort of think of it like imperforate anus. And you think of it as there's different ways of classifying imperforate anus. But for me, practically, there's high and there's low. ↗
▶ Ep 5 · 33:10
quote If NMEC is amplified, it is automatically high-risk disease, irrespective of any other categorization. ↗
▶ Ep 5 · 35:25
guideline Age cutoff for neuroblastoma risk stratification is 18 months (previously was 12 months) ↗
▶ Ep 5 · 45:31
clinical Stem cell harvesting for high-risk neuroblastoma typically occurs after cycle 2 of chemotherapy ↗
▶ Ep 5 · 46:50
clinical Recent German/European publication stated unequivocally that extent of resection does not make a difference in neuroblastoma outcomes ↗
▶ Ep 5 · 47:20
quote I think the bottom line is patients don't die of local disease. They die of systemic disease, in neuroblastoma. ↗
▶ Ep 5 · 47:40
clinical High-risk neuroblastoma patients die of metastatic disease, not local disease recurrence ↗
▶ Ep 5 · 53:13
clinical Nephrectomy should be avoided in neuroblastoma resection because kidney removal requires chemotherapy dose reduction ↗
▶ Ep 5 · 53:44
clinical Anti-GD2 monoclonal antibody improved high-risk neuroblastoma two-year survival from 46% to 60% ↗
▶ Ep 5 · 54:40
clinical Checkpoint inhibitors have not been successful in neuroblastoma because it is not an immunogenic tumor ↗
Tony's statements about Wilms Tumor 32 statements

Open the Wilms Tumor collection →

Compiled Sandler Rapid Fire Sessions: Update Course 2015

▶ Ep 4 · 0:28
quote I congratulate you for putting on an incredible symposium ↗
▶ Ep 4 · 1:32
guideline Current standard for bilateral Wilms tumor is to start chemotherapy without biopsy, typically 2 cycles, and continue until tumor shrinkage plateaus (defined as less than 50% size reduction) ↗
▶ Ep 4 · 4:19
clinical When Wilms tumors stop shrinking with chemotherapy, it is usually due to mesenchymal differentiation rather than anaplastic transformation ↗
▶ Ep 4 · 4:44
clinical Bilateral nephron-sparing surgery is feasible even in large bilateral Wilms tumors by placing kidneys on ice, clamping vessels, and performing sharp dissection ↗
▶ Ep 4 · 5:58
quote I never like to stick around for post-op complications. I, I'm that's a joke, sorry. ↗
▶ Ep 4 · 6:46
quote They gotta look a lot. You have to look a lot. ↗
▶ Ep 4 · 7:56
opinion Most pathologists believe anaplasia in Wilms tumor is present primarily rather than induced by chemotherapy ↗
▶ Ep 4 · 9:12
epidemiological 97% of bilateral kidney tumors in children are Wilms tumor, with only a small percentage being other diagnoses ↗
▶ Ep 4 · 12:54
clinical Umbilical hernias after gastroschisis closure will close spontaneously if no fascia was cut; if fascia is cut, a permanent defect results ↗
▶ Ep 4 · 14:52
clinical Tegaderm closure of gastroschisis without fascial closure allows cicatrization over 3 days to 8 weeks, with feeding started when bowel function returns rather than waiting for complete closure ↗
▶ Ep 4 · 15:32
clinical When gastroschisis defect dilates during silo reduction attempts, Tegaderm closure alone can still achieve successful cicatrization without fascial closure ↗
▶ Ep 4 · 21:01
clinical In vanishing gastroschisis with markedly inflamed bowel, it is impossible to determine bowel viability or the extent of remaining intra-abdominal bowel from external examination ↗
▶ Ep 4 · 21:11
quote You cannot tell what's going on with this bowel, whatever you, whatever you do. Now, something strange we did and absolutely not take it out, never take it out. ↗
▶ Ep 4 · 22:07
clinical Re-exploration at 2 weeks after gastroschisis closure (rather than the traditional 4-6 weeks) can reveal that inflamed gastroschisis bowel has transformed into functional intestine suitable for anastomosis ↗
▶ Ep 4 · 26:13
clinical Plication of dilated bowel in ileal atresia usually unravels with time, allowing the bowel to be used later for lengthening procedures ↗
▶ Ep 4 · 28:10
clinical In neonatal ileal atresia with dilated proximal bowel, plication is preferred over tapering to preserve bowel length for potential future lengthening procedures ↗

Neuroblastoma

▶ Ep 9 · 3:27
epidemiological Familial neuroblastoma occurs in approximately 1% of patients ↗
▶ Ep 9 · 8:41
quote I think one of the other things when you speak to the family, it's really important to reassure them that even if the mass increases in size and you take it out, it is likely to be a very, very low risk tumor. ↗
▶ Ep 9 · 9:09
clinical In the GetNucturne observation study of 84 patients, 16 (approximately 20%) underwent resection for growth or family preference, with 98% event-free survival and 100% overall survival ↗
▶ Ep 9 · 12:43
opinion Five centimeters is the size cutoff where most experts recommend surgical resection of neonatal neuroblastoma ↗
▶ Ep 9 · 23:50
clinical Open biopsy via retroperitoneal approach allows adequate tissue for NMEC amplification, ALK mutation, ploidy, and 11q status ↗
▶ Ep 9 · 31:38
clinical NMEC amplification automatically means high-risk neuroblastoma regardless of other factors ↗
▶ Ep 9 · 32:32
quote I sort of think of it like imperforate anus. And you think of it as there's different ways of classifying imperforate anus. But for me, practically, there's high and there's low. ↗
▶ Ep 9 · 33:10
quote If NMEC is amplified, it is automatically high-risk disease, irrespective of any other categorization. ↗
▶ Ep 9 · 35:25
guideline Age cutoff for neuroblastoma risk stratification is 18 months (previously was 12 months) ↗
▶ Ep 9 · 45:31
clinical Stem cell harvesting for high-risk neuroblastoma typically occurs after cycle 2 of chemotherapy ↗
▶ Ep 9 · 46:50
clinical Recent German/European publication stated unequivocally that extent of resection does not make a difference in neuroblastoma outcomes ↗
▶ Ep 9 · 47:20
quote I think the bottom line is patients don't die of local disease. They die of systemic disease, in neuroblastoma. ↗
▶ Ep 9 · 47:40
clinical High-risk neuroblastoma patients die of metastatic disease, not local disease recurrence ↗
▶ Ep 9 · 53:13
clinical Nephrectomy should be avoided in neuroblastoma resection because kidney removal requires chemotherapy dose reduction ↗
▶ Ep 9 · 53:44
clinical Anti-GD2 monoclonal antibody improved high-risk neuroblastoma two-year survival from 46% to 60% ↗
▶ Ep 9 · 54:40
clinical Checkpoint inhibitors have not been successful in neuroblastoma because it is not an immunogenic tumor ↗